Evaluation of the Abbott ARCHITECT Toxo IgM assay

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 3, 2009, Pages 275-282

  Sickinger, Eva ^a   Braun, Hans Bertram ^a   Praast, Gerald ^a   Stieler, Myriam ^a   Gundlach, Cordelia ^a   Birkenbach, Claudia ^a   Prostko, John ^b   Palafox, Mary Ann ^b   Frias, Edwin ^b   Hsu, Stephen ^b   Matias, Matthew ^b   Pucci, Dominick ^b   Hausmann, Michael ^a   Sagel, Ulrich ^c   Smith, Darwin ^b  

^a ABBOTT GMBH AND CO KG   (Germany)

^b ABBOTT DIAGNOSTICS   (United States)

^c AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

Author keywords

Acute infection; Toxo IgM; Toxoplasmosis

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; IMMUNOASSAY; PARASITE TRANSMISSION; PREGNANT WOMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEROCONVERSION; TOXOPLASMA GONDII; TOXOPLASMOSIS; VERTICAL TRANSMISSION;

ANIMALS; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN M; PREGNANCY; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TOXOPLASMA; TOXOPLASMOSIS;

EID: 67349158035     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.03.016     Document Type: Article

References (16)

1. Abgrall S., Rabaud C., and Costagliola D. Incidence and risk factors for toxoplasmic encephalitis in HIV-infected patients before and during the HAART era. Clin Infect Dis 33 (2001) 1747-1755
2. Bonnet F., Lewden C., May T., Heripret L., Jougla E., Bevilacqua S., Costagliola D., Salmon D., Chene G., Morlat P., and Mortalite 2000 Study Group. Opportunistic infections as causes of death in HIV-infected patients in the HAART era in France. Scand J Infect Dis 37 (2005) 482-487
3. Boyer K.M., Holfels E., Roizen N., Swisher C., Mack D., Remington J., Withers S., Meier P., McLeod R., and the Toxoplasmosis Study Group. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynecol 192 (2005) 564-571
4. Calderaro D., Piccolo G., Peruzzi S., Gorrini C., Chezzi C., and Dettori G. Evaluation of Toxoplasma gondii immunoglobulin G (IgG) and IgM assays incorporating the new Vidia Analyzer System. Clinical and Vaccine Immunology 15 (2008) 1076-1079
5. Candolfi E., Pastor R., Huber R., Filisetti D., and Villard O. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn Microbiol Infect Dis 58 (2007) 83-88
6. Dannemann B.R., Vaughan W.C., Thulliez P., and Remington J.S. Differential agglutination test for diagnosis of recently acquired infection with Toxoplasma gondii. J Clin Microbiol 28 (1990) 1928-1933
7. Fricker-Hidalgo H., Saddoux C., Suchel-Jambon A.S., Romand S., Foussadier A., Pelloux H., and Thulliez P. New VIDAS assay for Toxoplasma-specific IgG avidity: evaluation on 603 sera. Diagn Microbiol Infect Dis 56 (2006) 167-172
8. Hedman K., Lappalainen M., Seppälä I., and Mäkelä O. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 159 (1989) 736-740
9. Kasper D.C., Prusa A.R., Hayde M., Gerstl N., Pollak A., Herkner K.R., and Reiter-Reisacher R. Evaluation of the VITROS ECiQ immunodiagnostic system for detection of anti-Toxoplasma immunoglobulin G and immunoglobulin M antibodies for confirmatory testing of acute Toxoplasma infection in pregnant women. J Clin Microbiol 47 (2009) 164-167
10. Liesenfeld O., Press C., Montoya J.G., Gill R., Isaac-Renton J.L., Hedman K., and Remington J.S. False-positive results in immunoglobulin M (IgM) Toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 35 (1997) 174-178
11. Montoya J.G., and Liesenfeld O. Toxoplasmosis. Lancet 363 (2004) 1965-1976
12. Petersen E., Borobio M.V., Guy E., Liesenfeld O., Meroni V., Naessens A., Spranzi E., and Thulliez P. European multicenter study of the LIAISON automated diagnostic system for determination of Toxoplasma gondii-specific immunoglobulin G (IgG) and IgM and the IgG avidity index. J Clin Microbiol 43 (2005) 1570-1574
13. Remington J.S., McLeod R., Thulliez P., and Desmonts G. Toxoplasmosis. In: Remington J.S., Klein J.O., Wilson C.B., and Baker C. (Eds). Infectious diseases of the fetus and newborn infant. 6th ed (2006), Elsevier Saunders, Philadelphia 947-1091
14. Sickinger E., Gay-Andrieu F., Jonas G., Schultess J., Stieler M., Smith D., Hausmann M., Stricker R., Stricker R., Dhein J., and Braun H.B. Performance characteristics of the new ARCHITECT Toxo IgG and Toxo IgG Avidity assays. Diag Microbiol and Infect Dis 62 (2008) 235-244
15. Thulliez P., Remington J.S., Santoro F., Ovlaque G., Sharma S., and Desmonts G. A new agglutination test for the diagnosis of acute and chronic Toxoplasma infection. Path Biol 34 (1986) 173-177
16. Wilson M., Remington J.S., Clavet C., Varney G., Press C., and Ware D. Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. J Clin Microbiol 35 (1997) 3112-3115